Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport

Table 4

Multivariate logistic regression analysis for risk factors for ICU mortality in critically ill patients with iNO treatment.

	OR^a	95% CI^b of OR	value
Maximal iNO dosage during ICU^c stay (ppm, mean ± SD)	1.042	1.009–1.077	0.013
Duration of MV^d during ICU stay (days, mean ± SD)	0.932	0.895–0.97	0.001
Vasopressors support (mean ± SD)	64.01	2.095–195.5	0.017

^aOR: odds ratio. ^bCI: confidence interval. ^cICU: intensive care unit. ^dMV: mechanical ventilation.